Prevalence of vitamin D and vitamin B12 deficiency in patients reporting to the West Bank governmental hospitals in the period betweenJanuary 2015 and December 2018 by Al-Qtishat, Bayan et al.
16
Al-Qtishat, B. et al. Al-Quds J Acad Res  2021: 1(1):16-23
https://doi.org/10.47874/2021p2
 Prevalence of vitamin D and vitamin B12
 deficiency in patients reporting to the West Bank
 governmental hospitals in the period between
January 2015 and December 2018
RESEARCH
Bayan Al-Qtishat, Ahmed Al-Jawabreh, and Dina M. Bitar*
Faculty of Medicine, Al-Quds University, Jerusalem, Palestine 
A B S T R A C T
Vitamin D and vitamin B12 deficiencies are major public health problems; they may result from inappropriate low exposure to 
sunlight, autoimmune diseases or diminished intake. These two deficiencies have been extensively studied globally: causes, 
e!ects, treatment, as well as  epidemiology. In Palestine the epidemiology of vitamin D and vitamin B12 deficiencies has 
not been addressed. This study was undertaken to determine the prevalence of vitamin D and vitamin B12 deficiencies in 
patients reporting to the West Bank (WB) governmental hospitals in the period between January 2015 and December 2018. It 
is a retrospective cross-sectional study for the data collected from medical records of patients tested for these deficiencies 
in 12 WB governmental hospitals for the three years period. Out of 30890 patients tested for vitamin D levels, 88% had 
insu"cient vitamin D levels (< 30 ng/ml), whereas out of 43532 patients tested for vitamin B12, 19% had insu"cient vitamin 
B12 levels (< 203 pg/ml). The percentage of patients with insu"cient vitamin D levels is alarming. The percentage of patients 
with insu"cient vitamin B12 levels falls within ranges reported by other studies in various countries. In conclusion, this study 
revealed an alarmingly high percentage (88%) of vitamin D deficiency below the reference su"ciency level among patients 
suspected to have such a deficiency. Around one fifth of the patients tested for vitamin B12 had insu"cient levels. Because 
testing for vitamin D is costly, we suggest, that medical suspicion of vitamin D deficiency would be adequate to initiate 
treatment to alleviate the expense, especially in high-risk groups such as elderly women. Future studies have to address 
major risk factors contributing to these deficiencies that are specific to our community.  
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Introduction
Vitamin D and vitamin B12 play critical 
roles in the human body and in its development.
Vitamin D was previously associated with 
calcium absorption and healthy bones only.
Nowadays, with more recent studies showing 
that the vitamin D receptor is present on almost 
all cell membranes (Szabó 2011), we understand 
that it has more sophisticated functions. For 
example, potent inhibition of cellular growth 
and renin production, stimulation for insulin 
release, intrinsic factor production, and immune 
modulation (Haroon & Regan, 2010). Vitamin 
D deficiency leads to a variety of conditions 
starting with mild muscle pain and weakness 
to increased risk of osteoporosis or worse yet 
cancers and autoimmune diseases (Sahota, 2014). 
Vitamin D3 is obtained from the diet and from 
sunlight exposure. It is formed in the skin as a 
result of exposure to UBV radiation between 280 
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and 315nm wavelengths on 7 dihydrocholestrol, a 
substance normally found in the skin. It is then 
converted to 25-hydroxyvitamin D (25(oH)D) in 
the liver; the storage form, which is the form 
used as an indicator for serum vitamin D status. 
Further metabolism occurs in the kidneys giving 
the biologically active form 1,25 hydroxyvitamin D 
(1,25-(oH)D) also known as calcitriol (Sahota 2014). 
Vitamin B12 functions in myelination of the nerves 
and long-term maintenance of the nervous system. 
It also has a major role in red blood cell formation. 
Vitamin B12 deficiency leads to megaloblastic 
anemia and combined subacute degeneration of the 
spinal cord, which manifests as general weakness, 
tingling or numbness in hands and/or feet and 
confusion (Oberley & Yang 2013). Vitamin B12 
(cobalamin) cannot be synthesized in the human 
body and needs to be obtained from the diet such 
as meat, eggs and dairy products (Green et al., 
2017). There are two assays used for measuring 
25(oH)D in the serum. The golden test is by 
employing chromatography, the other is immune-
based assay, which is the most commonly used 
assay in clinical practice (Sahota 2014). The cuto! 
point to determine deficiency or insu"ciency of 
vitamin D remains a controversy; di!erent studies 
use di!erent reference levels.
The Institute of Medicine (IOM) report in 2011 
indicated that adequate levels of vitamin D range 
between 50 -125 nmol/l (20 -50 ng/ml) (Ross et al., 
2011). In this study, based on the cuto! points by 
the IOM for vitamin D, levels lower than 75 nmol/l 
(30 ng/mL) were considered as insu"cient, lower 
than 50 nmol/l (20 ng/mL) as deficiency levels, 
and higher than 125 nmol/l (50 ng/mL) as harmful 
levels. However, clinical deficiency only shows in 
levels lower than 25 nmol/l (10 ng/mL). To diagnose 
vitamin B12 deficiency, total serum vitamin B12 
concentration is measured. Di!erent cuto! 
values are used to determine vitamin B12 status. 
However, according to the WHO, the cuto! value 
suggested for defining vitamin B12 deficiency is 
< 203 pg/ml (150 pmol/L) serum vitamin B12. In 
this study, the normal reference range for serum 
vitamin B12 will be considered to be between 
200 - 900 pg/ml (Hannibal et al., 2017). In Jordan, 
one-third of the adult population (age >18 years) 
su!er from vitamin B12 deficiency (levels below 
200 pg/ml) with no di!erence between males and 
females (El-Khateeb et al., 2014). Vitamin D and 
vitamin B12 deficiencies appear to be a pandemic 
phenomenon, but still not well characterized 
in Palestine, thus this study is an attempt to 
provide more insight into the status of these two 
vitamins in the Palestinian population. 
This study aimed to fill the gap between 
public perception of the extent of this health 
problem and actual data. Lastly, it is an e!ort 
to direct the spotlight on the wealth of data, 
the Palestinian health care system has and 
to illustrate how this rich pool of data can be 
utilized for studies that would altogether give a 
clear picture of the health status in Palestine.
Materials and methods
    This study is a retrospective cross-sectional study. 
The data was collected from twelve governmental 
hospitals’ medical records covering the northern, 
central and southern governorates. The data was 
kindly provided by the information technology 
department in the Palestinian ministry of health. 
The collected data included all vitamin B12 and 
vitamin D test results during the period between 
Jan 2015 to Dec 2018, along with the demographic 
patients’ data including age, gender, and city of 
residence. The collection was done separately for 
each vitamin and for each year. 
Permission to collect this data was obtained 
from the health education department, ministry of 
health (letter number: 162/1881/2018 on 19/11/2018).
The total number of data collected for vitamin D 
and vitamin B12 was 32994 and 48191 respectively. 
The data was filtered by removing items that did 
not include all the targeted information; leaving 
30890 valid items for vitamin D, and 44916 for 
vitamin B12. Additional filtering for vitamin B12 
data was done by removing the outliers (any test 
result above 950 pg/ml or below 50 pg/ml). This was 
necessary because high levels (>950 pg/ml) may 
indicate assay technical failure, liver disease or 
occult malignancy etc; while levels below (50 pg/
ml) can be seen in pregnancy, folic acid deficiency 
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etc. (Oberley & Yang 2013). The final sample size 
for Vitamin B12 was accordingly 43532. The details 
on outliers are provided in Table 1.




























All the data was analyzed using Statistix 2.0 
Results
Vitamin D Results
The sample size collected from hospitals’ 
records, examined for vitamin D status after 
filtering was 30890. Females represented 71% 
(22060) of the sample with a mean ± SD of (16 ng/
ml ± 15) Vitamin D level, 88 % of which were below 
normal levels (30-49.9 ng/ml). Males represented 
29% (8830), with a mean ± SD Vitamin D level of 
(18 ng/ml ± 15.5), 89 % of which were below the 
normal levels.
Eighty eight percent of all the samples 
tested had a vitamin D level below normal (30 
ng/ml), with the following distribution: 15% with 
insu"ciency (20-29.9 ng/ml), 31% with deficiency 
(10-19.9 ng/ml) and 42% with clinical deficiency 
























Table 3: Vitamin D status (ng/ml) trend within years (2015-2018)
2018201720162015Year
13862119724705387Number of patients 
tested
17161516Mean of vitamin D ng/ml
19151311Std. Deviation
Table 2: Distribution of Vitamin D status (ng/ml)
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As shown in Table 3, the number of patients 
who were tested for vitamin D deficiency increased 
from 387 in 2015 to 13862 in 2018 which represents 
35.8x fold, with an insignificant improvement in 
vitamin D deficiency from a mean ± SD  of (16 ng/
ml ± 11)   in 2015 to (17 ng/ml ± 19) in 2018.  
Further description of the vitamin D status (ng/
ml) according to the city and the age of the 
patients tested are shown in Figures 1 and 2 
respectively.
Vitamin D status (ng/ml) mean in all age groups 
was less than (20 ng/ml) indicating deficiency, 
with no significant di!erence as referred to the 
patient’s city origin. 
Vitamin B12
The number of patients examined for 
vitamin B12 deficiency and included in this 
investigation was 43534. Females represented 66 
% (28769) with a mean of vitamin B12 level pg/ml 
± SD, (335 pg/ml  ± 161), 18.6% of the females with 
deficiency levels, while males represented 34 % 
(14763) with a mean of vitamin B12 level pg/ml ± 
SD, (328 pg/ml  ± 161) with 19.7% with a deficiency 
level. Out of the total (43534) tested for vitamin 
B12 levels, 158 (19%) had B12 deficiency (<199.9 pg/
ml) as shown in Table 4.





























As shown in Table 5, the number of patients 
tested for vitamin B12 serum level increased from 
4789 in 2015 to 16559 in 2018 representing a 3.5x 
fold. Further description of the vitamin B12 mean 
according to the city and the age of the patients 
tested are shown in Figures 3 and 4 respectively.
Figure 1: Vitamin D status (ng/ml) trend within WB 
cities     
Figure 2: Vitamin D status (ng/ml) trend within age 
groups
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Figure 3: Vitamin B12 level (pg/ml) trend within WB 
cities     
Figure 4: Vitamin B12 level (pg/ml) within age groups  
    Vitamin B12 mean levels (pg/ml) for all patients 
examined between January 2015 and December 
2018 were within the normal range (Figure 3) and 
the same is true when the vitamin B12 levels in 
the patients from the di!erent cities (Figure 4) 
were compared.
Discussion
This study shows the extent of vitamin D 
and Vitamin B12 deficiencies in patients reporting 
to the West Bank governmental hospitals in the 
state of Palestine during the period 2015 – 2018.
The number of females examined for vitamin D 
deficiency was 2.4x fold greater than the number 
of males examined. The prevalence of deficiency 
between these two groups was similar, 88% 
below normal levels for the females and 89% 
below normal levels for the males. The mean level 
for vitamin D testing is (16 ng/ml ± 15), with 73% 
of the sample below the deficiency levels (10-19.9 
ng/ml) and 88% below the su"cient levels (30-50 
ng/ml). Previous studies on two subpopulations 
in Palestine similarly showed a high prevalence 
rate of vitamin D deficiency, in which 60.7% of 
the children were vitamin D deficient (Chaudhry, 
Hajat & Rizkallah, 2018). While the deficiency 
prevalence was 85.9% in postmenopausal women 
(Kharroubi, Saba, Smoom, Bader, & Darwish, 2017).
The prevalence of vitamin D deficiency in the 
neighboring countries is similarly high. In Syria, the 
prevalence of vitamin D deficiency is 61% (Sayed-
Hassan, Abazid, & Alourfi, 2014), while in Jordan it is 
60.3%( Nichols et al., 2012) and Saudi Arabia is 52.6% 
(Ardawi, Sibiany, Bakhsh, Qari, & Maimani, 2012). The 
overall vitamin D deficiency prevalence in the Middle 
East in a systematic review was found to be between 
30-90% depending on the type of study, country, age etc 
(Bassil, Rahme, Hoteit, & Fuleihan, 2013).  
In this current study, in the period between 
2015 and 2018 there was a remarkable increase 
(35.8x) in the number of patients tested for 
vitamin D levels. However, there was a small 
increase in the mean of vitamin D (Table 3). 
This slight increase may be due to increased 
public awareness of vitamin D deficiency and 
the increased use of vitamin D supplements; as 
noted by di!erent studies showing the increased 
use of supplements in di!erent subgroups (Lips 
et al., 2019). However, other studies still point out 
that vitamin D supplements’ use in the Middle 
East is not su"cient enough to fulfill the daily 
requirements of vitamin D (Hwalla et al., 2017).
    Use of Vitamin D supplements without testing: 
where do we stand? In a recent study dedicated 
to understand the current situation of vitamin D 
deficiency and means of its prevention in Europe 
and the Middle East; it was evident that the daily 
intake of vitamin D in the Middle East is not 
su"cient enough to meet the required daily dose 
Al-Qtishat, B et al. Al-Quds J Acad Res  2021: 1(1):16-23
21
of the vitamin. This same study recommended the 
use of vitamin D supplements in specific high risk 
populations including: children younger than the 
age of 1 year, pregnant women, persons living in 
institutions, persons older than the age of 70 and 
all non-Western immigrants (Lips et al., 2019). In 
the Netherlands, new vitamin D supplementation 
recommendations state that even adults with 
dark skin, or white skin adult but insu"cient skin 
exposure should be taking vitamin D supplements 
(Weggemans, Kromhout, & Van Weel, 2013. 
Two Middle Eastern countries; Saudi Arabia 
and United Arab Emirates have set recommendations 
for daily vitamin D supplementation taking into 
consideration the age and the reproductive 
status of the individual (Al-Daghri et al., 2017; 
Haq, Wimalawansa, Pludowski, & Al Anouti, 2018). 
However, the level of vitamin D supplement use 
in the Middle East is still low (Hwalla et al., 2017). 
In Palestine, the ministry of health recommends 
vitamin D supplementations for children from the 
age of 21 days until the age of 1 year. In spite 
of these recommendations, the prevalence of 
vitamin D deficiency in children as previously 
mentioned is 60.7% (Chaudhry et al., 2018). Recent 
studies have linked a genetic component to 
vitamin D concentration worldwide (Shea et  al., 
2009; Trummer et al., 2012). Some of the heritable 
polymorphisms linked to vitamin D deficiency 
level were evaluated in Saudi Arabia and further 
confirmed the link of two of them to vitamin D 
deficiency (Sadat-Ali, Al-Turki, Azam, & Al-Elq, 2016). 
In the light of the aforementioned studies 
and recommendations, and also given the high 
cost for vitamin D testing in Palestine; the use of 
vitamin D supplementation without testing may 
be recommended for patients who are considered 
high-risk groups or patients with high clinical 
suspicion for vitamin D deficiency. Moreover, the 
risk of vitamin D excess intake is low (Flynn et 
al., 2009). Most of the cases of vitamin D toxicity 
are related to errors in fortification of food or 
formulation of supplements specifically when 
unlicensed supplements are used (Taylor & Davies, 
2018). With the appropriate prescription and 
accurate explanation of supplement ingestion this 
problem can be avoided. Giving supplementation 
in the aforementioned subgroups of patients 
without testing might save the government and 
the individuals the expense of testing; which can 
be directed toward more comprehensive studies 
to evaluate the exact prevalence in the general 
population.
Vitamin B12 in comparison to vitamin D 
The number of females tested for vitamin 
B deficiency was 1.9x fold greater than the 
number of males tested, however both groups 
showed similar deficiency prevalence; 18.6% for 
the females and 19.7% for the males. According 
to a recent review about vitamin B12 deficiency, 
asymptomatic vitamin B12 deficiency ranges 
between 2.5% to 26%  (Green et al., 2017). 
In this study, 19% exhibited vitamin 
B12 deficiency, which falls within the general 
population range. The number of patients tested 
for vitamin B12 was larger than those tested for 
vitamin D. This surprising di!erence in deficiency 
levels of vitamin B12 and vitamin D is not unique 
and has been observed before (Yazici et al., 2019). 
However, it further emphasizes the need for more 
studies in this area for better understanding and 
improved management of these health problems. 
Highly noticeable for vitamin B12 results is the 
fact that the unfiltered data had abnormally high 
levels (above 2000 pg/ml) for vitamin B12, which 
may be an indication of lab error(s) or typing 
error(s) (Oberley & Yang, 2013); this may be due 
to several reasons including; under qualified 
lab workers, heavy workload on the laboratory 
technicians, or simply faulty equipment. This can 
be supported by the fact that the percentage of 
outliers was higher in certain hospitals more 
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than the others (Table 1). 
This study is a description of the current 
governmental hospital data; and does not take 
into account factors such as disease state, dietary 
habits, or the use of vitamin D or B12 supplements 
at the time of the test etc. Furthermore, a 
reconsideration for testing patients prior to 
giving supplements of vitamin D, especially for 
the subpopulations with the highest risk such as 
elderly women, in consideration with the current 
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